![July/August 2021: Comparing Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir for second-line HIV treatment: Results of the NADIA Trial in Uganda, Kenya, and Zimbabwe](https://icap.columbia.edu/wp-content/uploads/Journal-club-1080x675.jpg)
Uganda
![July/August 2021: Comparing Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir for second-line HIV treatment: Results of the NADIA Trial in Uganda, Kenya, and Zimbabwe](https://icap.columbia.edu/wp-content/uploads/Journal-club-1080x675.jpg)
![Special Webinar (Archived Recording) — Population Surveys: Measuring and Informing the HIV Response](https://icap.columbia.edu/wp-content/uploads/Webinar-Recordings-e1532366618694-1080x675.png)
Special Webinar (Archived Recording) — Population Surveys: Measuring and Informing the HIV Response
RECORDED: Thursday, July 1, 2021, 9:00 – 10:30 a.m. ET ACCESS THE RECORDING ACCESS THE SLIDES, including Q&A On Thursday, July 1, 2021, ICAP at Columbia University hosted a webinar to discuss population surveys and how their findings provide critical information...![May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis](https://icap.columbia.edu/wp-content/uploads/0-3-e1622128820264-1080x675.png)
May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...![April 2021: IMPAACT 2010/VESTED trial evaluates the virological efficacy and safety of ART regimens containing DTG when started in pregnancy](https://icap.columbia.edu/wp-content/uploads/GettyImages-1208393752-1-e1619719000287-1080x675.jpg)
April 2021: IMPAACT 2010/VESTED trial evaluates the virological efficacy and safety of ART regimens containing DTG when started in pregnancy
Article: Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT...![March 2021: Expanded, population-level access to PrEP through the SEARCH study, with a flexible service delivery model, associated with lower HIV incidence among PrEP initiators in rural communities in Kenya and Uganda](https://icap.columbia.edu/wp-content/uploads/0-8-e1617138200583-1080x675.jpg)